Formac Pharmaceuticals SA
Formac Pharmaceuticals reported total assets of 2,112 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).
The score of Formac Pharmaceuticals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -99 % Total assets -99 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Formac Pharmaceuticals's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 01 Aug 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 12 Jul 2022
Formac Pharmaceuticals's financial analysis
- Solvency100.0%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Formac Pharmaceuticals
Formac Pharmaceuticals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0892.914.395
- VAT number
- BE0892914395
- Peppol
- Registered · 0208:0892914395 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 03 Oct 2007
- Registered office
- 3001 Leuven
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Formac Pharmaceuticals (SA) has been based in Leuven since 2007, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 1,622 € and equity of 2,112 €; its revenue is not published. Its solvency stands at 100.0%, above the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Formac Pharmaceuticals
Companies in the same business, of comparable size and area, outside its group.
- Apcor R&M Manufacture of basic pharmaceutical products Ghent · balance sheet 5,677 €
- AJN Management Research and experimental development on natural sciences and engineering Molenbeek-Saint-Jean · balance sheet 4,176 €
- Focus Pharma Wholesale of pharmaceutical and medical goods Leuven · balance sheet 7,674 €
- Mandible Guide Research and experimental development on natural sciences and engineering Woluwe-Saint-Pierre · balance sheet 64,270 €
- Turnacum Wholesale of pharmaceutical and medical goods Tournai · balance sheet 25,766 €
- Congress Pharma Wholesale of pharmaceutical and medical goods Woluwe-Saint-Pierre · balance sheet 82,571 €
- MC Pharma Manufacture of basic pharmaceutical products Beaumont · balance sheet 28,699 €
- Hexacath Belgium Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 96,025 €
Frequently asked questions about Formac Pharmaceuticals
What is the revenue of Formac Pharmaceuticals?
Formac Pharmaceuticals files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Formac Pharmaceuticals?
In Belgium, the VAT number is the company number prefixed with BE: BE0892914395 for Formac Pharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 0892.914.395.
Where is the registered office of Formac Pharmaceuticals?
According to the CBE register, the registered office of Formac Pharmaceuticals is in 3001 Leuven.
What is the equity of Formac Pharmaceuticals?
At the close of the 2025 financial year, the equity of Formac Pharmaceuticals amounts to 2,112 €, a solvency of 100.0% of total assets.
Who manages Formac Pharmaceuticals?
The register lists 3 active mandates at Formac Pharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Formac Pharmaceuticals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →